Hikma Pharmaceuticals Plc
07 January 2008
For Immediate Release 7 January 2008
Hikma Pharmaceuticals PLC (the 'Company')
Director/PDMR Shareholding
Notification of Option Exercise
On 4 January 2008 the following Director exercised his option to purchase the
number of ordinary shares of 10 pence each set out in the table below in the
capital of the Company. These options were granted on the date shown below
pursuant to the Company's 2004 Stock Option Plan:
Name Date of Grant Number of Shares Exercised
Mazen Darwazah 12 October 2004 160,000
On 4 January 2008, the Director disposed of the following number of shares
acquired pursuant to the exercise of the options set out above:
Market Price
Names Date of Disposal on Disposal Number of Shares Disposed
Mazen Darwazah 4 January 2008 £4.85 160,000
As a result of the above transaction the Director listed below now has the
following holdings in the ordinary share capital of the Company:
Name Ordinary Shares in the Company Percentage of Share capital
Mazen Darwazah 61,958 0.329%
The issued share capital of Hikma Pharmaceuticals PLC is now 170,893,807
ordinary shares of 10 pence each.
Date of Notification: 7 January 2008
Henry Knowles
Company Secretary
020 7399 2760
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.